The Association between Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk in Children

Anna Di Sessa1, Giuseppina Rosaria Umano2, Emanuele Miraglia Del Giudice3

  • 1Department of Woman, Child and General and Specialized Surgery, University of Studies of Campania "Luigi Vanvitelli", 80138 Napoli, Italy. anna.disessa@libero.it.

Insights

Childhood obesity is increasing Non-Alcoholic Fatty Liver Disease (NAFLD) globally. Pediatric NAFLD is linked to cardiovascular disease (CVD) risk, including early heart abnormalities.

Area of Science:

  • Pediatric Cardiology
  • Hepatology
  • Public Health

Background:

  • Non-Alcoholic Fatty Liver Disease (NAFLD) is the leading cause of pediatric chronic liver disease globally.
  • Childhood obesity rates have significantly increased over recent decades, contributing to NAFLD prevalence.
  • Emerging evidence suggests a strong association between pediatric NAFLD and cardiovascular disease (CVD).

Purpose of the Study:

  • To review current knowledge on the relationship between pediatric NAFLD and cardiovascular risk.
  • To clarify the role of NAFLD as a potential cardiovascular risk factor in children.
  • To highlight early subclinical cardiovascular abnormalities associated with pediatric NAFLD.

Main Methods:

  • Literature review of existing studies on pediatric NAFLD and cardiovascular outcomes.
  • Analysis of data linking NAFLD to cardiovascular events and subclinical cardiac changes in children.
  • Synthesis of current understanding of NAFLD's impact on pediatric cardiovascular health.

Main Results:

  • Pediatric NAFLD is increasingly recognized as an independent risk factor for cardiovascular events.
  • NAFLD in children is associated with early, subclinical abnormalities in myocardial structure and function.
  • The link between NAFLD and cardiovascular risk is evident even in early childhood.

Conclusions:

  • Pediatric NAFLD represents a significant and emerging cardiovascular risk factor.
  • Early identification and management of NAFLD in children are crucial for mitigating future cardiovascular complications.
  • Further research is warranted to fully elucidate the mechanisms linking NAFLD to pediatric cardiovascular disease.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.0K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
512
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
615
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.7K